Mimic any cell type of your choosing with custom TruCytes™ biomarker cell mimics. Scalable, reproducible results tailored to your unique research needs.
At Slingshot Biosciences, we take an expert-driven, white-glove approach to customizing TruCytes™, precision-engineered cell mimics designed to replicate the phenotype and function critical to your research. Our process ensures exceptional support and seamless integration at every stage:
Begin with an easy, hassle-free way to explore TruCytes. Evaluate our technology with a simple kit, guided by expert consultation and onsite support from our highly trained Field Application Scientists. Feasibility assessments ensure downstream customization meets your specific requirements.
Work with our team to finalize specifications for your Custom TruCytes™ biomarker controls. Together, we’ll outline key milestones and deliver an optimized product, complete with a tailored protocol for your intended use. Our experts ensure smooth onboarding, even across multiple sites, and prepare you for seamless Scale-Up and Production phases.
We’ll support the verification and validation process, both internally and externally, to set the stage for successful adoption. With dedicated guidance, you’ll be ready to transition confidently into large-scale production.
Achieve scalable success with Custom TruCyte™ production finalized to meet your specifications. Whether you need a small batch or large-scale manufacturing, we’re with you every step of the way, offering performance check-ins and ongoing optimization to ensure long-term success.
TruCytes™ Custom Biomarker Controls enhance consistency, accuracy, and scalability for your specific research needs. Features include:
See how we helped Cerba Research create a custom TruCytes™ cell mimic for Ki-67, a critical protein in cancer research. The result, which was designed to mimic a specific biological expression, delivered far more consistency and accuracy than live cells.
“The power of Slingshot’s technology is so far unchallenged and requires researchers to reach out and ask for the biomarker controls that they need.”
Dr. Veronica Nash | US Regional Head of Flow Cytometry
Cerba Research
See how we helped Prolocor design the ideal control for their platelet FcγRIIa precision diagnostic test that quantifies FcγRIIa on the surface of platelets to guide clinical decision making.
“Clinicians need better tools to guide decision making on the choice of antiplatelet therapy in coronary artery disease patients, particularly after coronary stenting. The Prolocor pFCG® test will be an important asset as we tailor antiplatelet therapies to balance thrombotic and bleeding risk.”
Dominick J. Angiolillo, MD, PhD, FACC, FESC, FSCAI | Professor of Medicine, Chief, Division of Cardiology, Director, Thrombosis Research Center
University of Florida, College of Medicine-Jacksonville.
See how we partnered with Fred Hutch CPF QC to engineer custom CD3 T cell mimics with varying percentages of expression of the common CAR transduction marker epidermal growth factor receptor (EGFR) to validate their CAR T cell flow cytometry assays.
“In our search for reliable controls for cell therapy assays, partnering with Slingshot has been a game-changer. Together, we addressed significant challenges by engineering custom CD3 T-cell mimics.”
Amina Kariminia, Ph.D. | Immunologist, Analytical Development Scientist
Fred Hutch Cancer Center
Ready to get started? First, tell us a little about the research you’re doing and the specific cellular characteristics you’re trying to replicate. This will help us customize a mimic to your unique needs.
By using this website, you agree to the storing of cookies on your device. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy.
